Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
These initiatives aim to improve access to healthcare for rare disease patients
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Apollo continues to invest in genomics technology and research for better patient care
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Subscribe To Our Newsletter & Stay Updated
